EUVIMEDEUVIMED entdecken
Crossref

Artificial Intelligence-Advanced Imaging for Solid-Type Lung Adenocarcinoma: Towards Greater Clinical Relevance

Tomoki Nishida iD, Masahiro Yanagawa iD, Junya Sato, Daiki Nishigaki, Akinori Hata, Yoshikane Yamauchi iD, Yuichi Saito iD, Noriaki Sakakura iD, Yasushi Yatabe iD, Yasushi Shintani iD, Shoji Kido, Noriyuki Tomiyama und 1 weitere

European Journal of Cardio-Thoracic Surgery · 2025

DOI: 10.1093/ejcts/ezaf385 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Cardio-Thoracic Surgery, 2025. Verfasst von Tomoki Nishida und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Teikyo University School of Medicine, Tokyo, 173-8606, Japan. Hauptthemen laut MEDLINE: Artificial Intelligence, Adenocarcinoma of Lung, Lung Neoplasms, Tomography, X-Ray Computed. Die Arbeit nennt 29 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Non-small-cell lung cancer (NSCLC) lesions appearing solid on imaging are highly likely to be malignant. However, “solid” has a subjective definition. This study aimed to determine whether artificial intelligence (AI)-based imaging analysis can offer a more objective and clinically meaningful definition of solid tumours, specifically in regards to lymph node metastasis and prognosis.

Methods

This study included 216 patients with cN0 lung adenocarcinoma (pathological invasive diameter ≤ 30 mm) who underwent lobectomy with lymph node dissection. AI software was used to calculate the consolidation-to-tumour diameter (cD/tD) and volume (cV/tV) ratios, which were then compared with radiologist-defined cD/tD. To determine the optimal cutoff values, correlations between the pathological invasive diameter/tumour diameter ratio (PathoiD/tD) and lymph node metastasis were evaluated. Subsequently, these values were applied to a subset of tumours measuring ≤20 mm (n = 117) to determine their potential use in candidate selection for limited resection.

Results

A cV/tV cutoff value of ≥0.72 accurately predicted lymph node metastasis and improved concordance between AI and radiologist solid tumour assessment while maintaining a similar PathoiD/tD to the conventional (cD/tD = 1.0) threshold. Among tumours measuring ≤20 mm in the low solid-component group (cV/tV <0.72), lymph node metastases were not observed; the 5-year recurrence-free survival rate was 100%.

Conclusions

An AI-based volumetric analysis using a cV/tV threshold of ≥0.72 showed potential for predicting lymph node metastasis in this single-centre retrospective study of lung adenocarcinoma ≤30 mm. External validation in diverse, multicentre cohorts is essential before clinical implementation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Artificial IntelligenceAdenocarcinoma of LungLung NeoplasmsTomography, X-Ray ComputedHumansFemaleMaleMiddle AgedAgedLymphatic MetastasisRetrospective StudiesPneumonectomyPrognosisAged, 80 and overLymph Node ExcisionAdultClinical Relevance

Stichwörter der Autor:innen

artificial intelligencelymph node metastasispure-solid adenocarcinomatumour volume

Autor:innen und Institutionen

  • Department of Surgery, Teikyo University School of Medicine, Tokyo, 173-8606, Japan.
  • Department of General Thoracic Surgery, Shonan Kamakura General Hospital, Kamakura, 247-8533, Japan.
  • Department of Radiology, Osaka University Graduate School of Medicine, Osaka, 565-0871, Japan.
  • Department of Thoracic Surgery, Aichi Cancer Center, Nagoya, 464-8681, Japan.
  • Department of Diagnostic Pathology, National Cancer Center Hospital, Tokyo, 104-0045, Japan.
  • Department of General Thoracic Surgery, Osaka University Graduate School of Medicine, Osaka, 565-0871, Japan.

ORCID-Profile: Tomoki Nishida, Masahiro Yanagawa, Yoshikane Yamauchi, Yuichi Saito, Noriaki Sakakura, Yasushi Yatabe, Yasushi Shintani, Yukinori Sakao

Zitieren

APA

Nishida, T., Yanagawa, M., Sato, J., Nishigaki, D., Hata, A., Yamauchi, Y., Saito, Y., Sakakura, N., Yatabe, Y., Shintani, Y., Kido, S., Tomiyama, N., & Sakao, Y. (2025). Artificial Intelligence-Advanced Imaging for Solid-Type Lung Adenocarcinoma: Towards Greater Clinical Relevance. European Journal of Cardio-Thoracic Surgery. https://doi.org/10.1093/ejcts/ezaf385

Vancouver

Nishida T, Yanagawa M, Sato J, Nishigaki D, Hata A, Yamauchi Y, et al. Artificial Intelligence-Advanced Imaging for Solid-Type Lung Adenocarcinoma: Towards Greater Clinical Relevance. European Journal of Cardio-Thoracic Surgery. 2025. doi:10.1093/ejcts/ezaf385

BibTeX
@article{Nishida2025,
  author = {Nishida, Tomoki and Yanagawa, Masahiro and Sato, Junya and Nishigaki, Daiki and Hata, Akinori and Yamauchi, Yoshikane and Saito, Yuichi and Sakakura, Noriaki and Yatabe, Yasushi and Shintani, Yasushi and Kido, Shoji and Tomiyama, Noriyuki and Sakao, Yukinori},
  title = {Artificial Intelligence-Advanced Imaging for Solid-Type Lung Adenocarcinoma: Towards Greater Clinical Relevance},
  journal = {European Journal of Cardio-Thoracic Surgery},
  year = {2025},
  doi = {10.1093/ejcts/ezaf385}
}
Kostenlos starten →